Researchers at University of Pennsylvania have discovered stem cells in the esophagus of mice that were able to grow into tissue-like structures and when placed into immune-deficient mice were able to form parts of an esophagus lining.
The investigators report their findings online on Monday in the Journal of Clinical Investigation.
"The immediate implication is that we'll have a better understanding of the role of these stem cells in normal biology, as well as in regenerative and cancer biology," says senior author Anil Rustgi. "Down the road, we might use these stem cells in replacement therapy for diseases like gastroesophogeal reflux disease (GERD) and also to understand Barrett's esophagus, a precursor to esophageal adenocarcinoma and how to reverse that before it becomes cancer."
The researchers set out to identify and characterize potential stem cells -- those with the ability to self renew -- in the esophagus to understand normal biology and how injured cells may one day be repaired.
First, they grew mouse esophageal cells they suspected were adult stem cells. Those cells formed colonies that self renewed. These cells then grew into esophageal lining tissue in a three- dimensional culture apparatus. "These tissue culture cells formed a mature epithelium sitting on top of the matrix," says Rustgi.
They then tested their pieces of esophageal lining in whole animals. When the tissue-engineered patches were transplanted under the skin of immune-deficient mice, the cells formed epithelial structures. Additionally, in a mouse model of injury of the esophagus in a normal mouse, which mimics what happens during acid reflux, green-stained stem cells migrated to the injured lining cells and co-labeled with the repaired cells, indicating involvement of the stem cells in tissue repair and regeneration.
Eventually the researchers will develop genetically engineered mouse models to be able to track molecular markers of esophageal stem cells. The group has already developed a library of human esophageal cell lines and is looking for human versions of markers already identified in mice.
"The ultimate goal is to identify esophageal stem cells in a patient, grow the patient's own stem cells, and inject them locally to replace diseased tissue with normal lining," says Rustgi. |
About Us 
